MMP7 and neoplasm: In addition, impaired MMP7, MMP9, and ADAM9 expression were found in ALOC-EO-treated B16F10 cells in a dose-dependent manner in vitro (Figure 2C,D) indicating that ALOC-EO suppresses the expression of tumor cell-derived proteases.